Albano L et al. |
OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation. |
2013 |
Transplantation |
pmid:23982340
|
Cacciarelli TV et al. |
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. |
1999 |
Transplantation |
pmid:10507484
|
Therapondos G et al. |
Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both? |
2003 |
Transplantation |
pmid:12883220
|
Fredericks S et al. |
Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements. |
2006 |
Transplantation |
pmid:16969296
|
Ogunseinde BA et al. |
A case of tacrolimus (FK506)-induced pancreatitis and fatality 2 years postcadaveric renal transplant. |
2003 |
Transplantation |
pmid:12883222
|
David-Neto E et al. |
Longitudinal Pharmacokinetics of Everolimus When Combined With Low-level of Tacrolimus in Elderly Renal Transplant Recipients. |
2017 |
Transplantation |
pmid:27798513
|
Marcos A et al. |
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. |
2004 |
Transplantation |
pmid:15480160
|
Gralla J and Wiseman AC |
Tacrolimus/sirolimus versus tacrolimus/mycophenolate in kidney transplantation: improved 3-year graft and patient survival in recent era. |
2009 |
Transplantation |
pmid:19502965
|
Morrissey PE |
Prope tolerance: is it the end or the means? |
2009 |
Transplantation |
pmid:19502973
|
Alloway RR |
Mounting Clinical Evidence With Tacrolimus Generic Products. |
2017 |
Transplantation |
pmid:28749820
|
Prókai à et al. |
Calcineurin-inhibition Results in Upregulation of Local Renin and Subsequent Vascular Endothelial Growth Factor Production in Renal Collecting Ducts. |
2016 |
Transplantation |
pmid:26502369
|
Lee D et al. |
Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression. |
2017 |
Transplantation |
pmid:27779572
|
Todo S et al. |
Abdominal multivisceral transplantation. |
1995 |
Transplantation |
pmid:7530873
|
Boleslawski E et al. |
Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. |
2004 |
Transplantation |
pmid:15223897
|
Wozniak LJ et al. |
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. |
2015 |
Transplantation |
pmid:26038872
|
Hostettler KE et al. |
Cyclosporine A mediates fibroproliferation through epithelial cells. |
2004 |
Transplantation |
pmid:15223908
|
Yang CW et al. |
Preconditioning with cyclosporine A or FK506 differentially regulates mitogen-activated protein kinase expression in rat kidneys with ischemia/reperfusion injury. |
2003 |
Transplantation |
pmid:12544865
|
Kuypers DR et al. |
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: the need for true drug exposure measurements. |
2010 |
Transplantation |
pmid:20555228
|
Lykavieris P et al. |
Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppression. |
2003 |
Transplantation |
pmid:12544888
|
Moffatt SD et al. |
Potential for improved therapeutic index of FK506 in liposomal formulation demonstrated in a mouse cardiac allograft model. |
1999 |
Transplantation |
pmid:10342309
|
Guethoff S et al. |
Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation. |
2013 |
Transplantation |
pmid:23423270
|
Bilolo KK et al. |
Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat. |
2003 |
Transplantation |
pmid:12811249
|
Miyakoshi S et al. |
Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases. |
2007 |
Transplantation |
pmid:17700155
|
Naesens M et al. |
The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide. |
2007 |
Transplantation |
pmid:17700162
|
Huang E et al. |
Alemtuzumab induction in deceased donor kidney transplantation. |
2007 |
Transplantation |
pmid:17984833
|
Kato T et al. |
Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year. |
2007 |
Transplantation |
pmid:17984834
|
Tze WJ et al. |
In vitro effects of FK-506 on human and rat islets. |
1990 |
Transplantation |
pmid:1694319
|
Reese JC et al. |
The effect of FK506 on canine bile flow. |
1993 |
Transplantation |
pmid:7504342
|
Utsugi R et al. |
Induction of transplantation tolerance with a short course of tacrolimus (FK506): I. Rapid and stable tolerance to two-haplotype fully mhc-mismatched kidney allografts in miniature swine. |
2001 |
Transplantation |
pmid:11391221
|
Woodle ES et al. |
FK506--reversal of humorally mediated cardiac allograft rejection in the presence of preformed anti-class I antibody. |
1993 |
Transplantation |
pmid:7504346
|
Yin DP et al. |
Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. |
2001 |
Transplantation |
pmid:11391223
|
Cox KL et al. |
An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. |
1995 |
Transplantation |
pmid:7533344
|
McDiarmid SV et al. |
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. |
1995 |
Transplantation |
pmid:7533345
|
Krentz AJ |
Posttransplantation Diabetes Mellitus in FK-506-Treated Renal Transplant Recipients: Analysis of Incidence and Risk Factors. Transplantation 2001; 72: 1655. |
2001 |
Transplantation |
pmid:11726815
|
Eberhard OK et al. |
How best to use tacrolimus (FK506) for treatment of steroid- and OKT3-resistant rejection after renal transplantation. |
1996 |
Transplantation |
pmid:8629294
|
Bruce DS et al. |
Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients. |
2001 |
Transplantation |
pmid:11726823
|
Jeske HC et al. |
Gemcitabine with cyclosporine or with tacrolimus exerts a synergistic effect and induces tolerance in the rat. |
2003 |
Transplantation |
pmid:14557751
|
Maes BD et al. |
Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. |
2001 |
Transplantation |
pmid:11726827
|
Loucaidou M et al. |
Five-year results of kidney transplantation under tacrolimus-based regimes: the persisting significance of vascular rejection. |
2003 |
Transplantation |
pmid:14557763
|
Toso C et al. |
Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients. |
2003 |
Transplantation |
pmid:14557767
|
Muthukumar T et al. |
HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles. |
2013 |
Transplantation |
pmid:23503504
|
King-Biggs MB et al. |
Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. |
2003 |
Transplantation |
pmid:12792493
|
Vu MD et al. |
Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts. |
2003 |
Transplantation |
pmid:12792496
|
Hricik DE et al. |
Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus. |
2007 |
Transplantation |
pmid:17297401
|
Hill CC et al. |
Penile prosthesis surgery in the immunosuppressed patient. |
1993 |
Transplantation |
pmid:7692633
|
Yanchar NL et al. |
Tacrolimus (FK506)--its effects on intestinal glucose transport. |
1996 |
Transplantation |
pmid:8610392
|
Solez K et al. |
Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. |
1998 |
Transplantation |
pmid:9884269
|
Roberts JP et al. |
Reversal of chronic rejection after treatment failure with FK506 and RS61443. |
1993 |
Transplantation |
pmid:7692634
|
Hariharan S et al. |
Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity. |
1996 |
Transplantation |
pmid:8610411
|
Reyes J et al. |
Expressive dysphasia possibly related to FK506 in two liver transplant recipients. |
1990 |
Transplantation |
pmid:1701571
|
Cacciarelli TV et al. |
Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation. |
1996 |
Transplantation |
pmid:8610416
|
Thervet E et al. |
Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients. |
2003 |
Transplantation |
pmid:14578760
|
Jain A et al. |
Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. |
2000 |
Transplantation |
pmid:10972220
|
Sharif A et al. |
Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression. |
2010 |
Transplantation |
pmid:20145524
|
Abu-Qaoud MS et al. |
Lack of relationship between microvascular and macrovascular disease in heart transplant recipients. |
2012 |
Transplantation |
pmid:23044666
|
Kaplan B et al. |
Frequency of hyperkalemia in recipients of simultaneous pancreas and kidney transplants with bladder drainage. |
1996 |
Transplantation |
pmid:8900321
|
Ciancio G et al. |
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: four-year analysis. |
2011 |
Transplantation |
pmid:21107305
|
Woodward RS et al. |
Renal graft survival and calcineurin inhibitor. |
2005 |
Transplantation |
pmid:16177637
|
Merkle M et al. |
The effect of sevelamer on tacrolimus target levels. |
2005 |
Transplantation |
pmid:16177649
|
Textor SC et al. |
Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. |
1993 |
Transplantation |
pmid:7685934
|
Arzouk N et al. |
Interaction between tacrolimus and fumagillin in two kidney transplant recipients. |
2006 |
Transplantation |
pmid:16421493
|
Maes BD et al. |
Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine. |
1999 |
Transplantation |
pmid:10589943
|
Gruber SA et al. |
Initial results of solitary pancreas transplants performed without regard to donor/recipient HLA mismatching. |
2000 |
Transplantation |
pmid:10933170
|
Shapiro R et al. |
Alopecia as a consequence of tacrolimus therapy. |
1998 |
Transplantation |
pmid:9603186
|
Muraki T et al. |
Effects of cyclosporine and FK506 on in vitro high shear-induced platelet reactivity in rat and human non-anticoagulated blood. |
1998 |
Transplantation |
pmid:9583878
|
Fernandez LA et al. |
The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. |
1999 |
Transplantation |
pmid:10589951
|
Kadry Z et al. |
Kaposi's sarcoma in liver transplant recipients on FK506. |
1998 |
Transplantation |
pmid:9583882
|
Mehra MR et al. |
Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. |
2002 |
Transplantation |
pmid:12490790
|
Batten P et al. |
Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro. |
1999 |
Transplantation |
pmid:10589954
|
Kandula P et al. |
Impact of tacrolimus-sirolimus maintenance immunosuppression on proteinuria and kidney function in pancreas transplant alone recipients. |
2012 |
Transplantation |
pmid:23037007
|
Dickenmann MJ et al. |
Blood eosinophilia in tacrolimus-treated patients: an indicator of Pneumocystis carinii pneumonia. |
1999 |
Transplantation |
pmid:10589963
|
First MR et al. |
New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials. |
2013 |
Transplantation |
pmid:23619735
|
Woodle ES et al. |
FK506: inhibition of humoral mechanisms of hepatic allograft rejection. |
1992 |
Transplantation |
pmid:1379749
|
Uemura T et al. |
Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation. |
2011 |
Transplantation |
pmid:21841541
|
Thorp M et al. |
The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol. |
2000 |
Transplantation |
pmid:10762229
|
Sulanc E et al. |
New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines. |
2005 |
Transplantation |
pmid:16249743
|
Jacobson PA et al. |
Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium. |
2011 |
Transplantation |
pmid:21206424
|
Ko S et al. |
The enhanced immunosuppressive efficacy of newly developed liposomal FK506 in canine liver transplantation. |
1995 |
Transplantation |
pmid:7539553
|
Holt S and Moore K |
Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. |
2002 |
Transplantation |
pmid:11907407
|
Fealy MJ et al. |
Association of down-regulation of cytokine activity with rat hind limb allograft survival. |
1995 |
Transplantation |
pmid:7539555
|
Yang H et al. |
Liposomal encapsulation significantly enchances the immunosuppressive effect of tacrolimus in a discordant islet xenotransplant model. |
2002 |
Transplantation |
pmid:11907415
|
St A Nunes FA and Lucey MR |
Searching for a balance when applying immunosuppression after liver transplantation. |
2001 |
Transplantation |
pmid:11258425
|
Nguyen L et al. |
Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipients. |
2012 |
Transplantation |
pmid:22960763
|
Vafadari R et al. |
Pharmacodynamic analysis of tofacitinib and basiliximab in kidney allograft recipients. |
2012 |
Transplantation |
pmid:22960764
|
Opelz G and Döhler B |
Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation. |
2009 |
Transplantation |
pmid:19300179
|
Rostambeigi N et al. |
Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunction. |
2011 |
Transplantation |
pmid:21200364
|
Mikhalski D et al. |
Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. |
2008 |
Transplantation |
pmid:18401260
|
Thomas PG et al. |
Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation. |
2007 |
Transplantation |
pmid:17565326
|
Nankivell BJ et al. |
Oral cyclosporine but not tacrolimus reduces renal transplant blood flow. |
2004 |
Transplantation |
pmid:15167607
|
Gibson SW et al. |
Nutritional immunomodulation leads to enhanced allograft survival in combination with cyclosporine A and rapamycin, but not FK506. |
2000 |
Transplantation |
pmid:10852592
|
Ciancio G et al. |
A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab. |
2013 |
Transplantation |
pmid:23903014
|
Konrad T et al. |
Regulation of glucose tolerance in patients after liver transplantation: impact of cyclosporin versus tacrolimus therapy. |
2000 |
Transplantation |
pmid:10852599
|
Warty V et al. |
FK506: a novel immunosuppressive agent. Characteristics of binding and uptake by human lymphocytes. |
1988 |
Transplantation |
pmid:2458643
|
Lerut J et al. |
Anti-CD2 monoclonal antibody and tacrolimus in adult liver transplantation. |
2005 |
Transplantation |
pmid:16314784
|
Wissing KM et al. |
Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation. |
2006 |
Transplantation |
pmid:17006324
|
Gruessner RW et al. |
Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus. |
2008 |
Transplantation |
pmid:18192910
|
Komori K et al. |
The role of graft and host accommodation in a hamster-to-rat cardiac transplantation model. |
2008 |
Transplantation |
pmid:18192920
|
Meiser BM et al. |
Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? |
2004 |
Transplantation |
pmid:15446320
|
Langrehr JM et al. |
Clinical course, morphology, and treatment of chronically rejecting small bowel allografts. |
1993 |
Transplantation |
pmid:7679526
|
Uemoto S et al. |
Experience with FK506 in living-related liver transplantation. |
1993 |
Transplantation |
pmid:7679528
|